Key pointsr We determined if bed rest increased mitochondrially derived reactive oxygen species and cellular redox stress, contributing to the induction of insulin resistance.r Bed rest decreased maximal and submaximal ADP-stimulated mitochondrial respiration. r Bed rest did not alter mitochondrial H 2 O 2 emission in the presence of ADP concentrations indicative of resting muscle, the ratio of H 2 O 2 emission to mitochondrial O 2 consumption or markers of oxidative stress r The present data suggest strongly that mitochondrial H 2 O 2 does not contribute to bed rest-induced insulin resistance Abstract Mitochondrial H 2 O 2 has been causally linked to diet-induced insulin resistance, although it remains unclear if muscle disuse similarly increases mitochondrial H 2 O 2 . Therefore, we investigated the potential that an increase in skeletal muscle mitochondrial H 2 O 2 emission, potentially as a result of decreased ADP sensitivity, contributes to cellular redox stress and the induction of insulin resistance during short-term bed rest in 20 healthy males. Bed rest led to a decline in glucose infusion rate during a hyperinsulinaemic-euglycaemic clamp (−42 ± 2%; P < 0.001), and in permeabilized skeletal muscle fibres it decreased OXPHOS protein content (−16 ± 8%) and mitochondrial respiration across a range of ADP concentrations (−13 ± 5%). While bed rest tended to increase maximal mitochondrial H 2 O 2 emission rates (P = 0.053), H 2 O 2 emission in the presence of ADP concentrations indicative of resting muscle, the ratio of H 2 O 2 emission to mitochondrial O 2 consumption, and markers of oxidative stress were not altered following bed rest. Altogether, while bed rest impairs mitochondrial ADP-stimulated respiration, an increase in mitochondrial H 2 O 2 emission does not contribute to the induction of insulin resistance following short-term bed rest.Marlou Dirks is a Sir Henry Wellcome Postdoctoral Fellow in the Department of Sport and Health Sciences at the University of Exeter, UK. Her research focuses on the impact of muscle disuse on metabolic health and the regulation of skeletal muscle protein turnover. Dr Dirks applies detailed in vivo metabolic techniques in experimental models of muscle disuse (i.e. bed rest, limb immobilization) to gain mechanistic insight into disuse-induced muscle atrophy and investigate potential interventional strategies for the preservation of muscle mass and metabolic health during muscle disuse.
Clinical trial registration: NCT02521025
Methods
SubjectsTwenty healthy, recreationally active males (age 25 ± 1 years) were included in the present study. Subjects'